Luminae Research produces hormone-binding intelligence reports for premium supplement and wellness brands — grounded in computational molecular modeling borrowed from pharmaceutical drug discovery.
We adapt computational techniques from pharmaceutical drug discovery to screen food and botanical compounds — through a female hormone receptor lens.
| Compound | Receptor | ΔG | Signal |
|---|---|---|---|
| Quercetin | ERβ | −8.4 | Strong |
| Rutin | ERβ | −7.9 | Strong |
| Betulinic acid | ERβ | −7.2 | Moderate |
| Oleanolic acid | ERβ | −6.8 | Moderate |
| Spinosin | ERβ | −6.1 | Moderate |
| Compound | Target | ΔG observed | Expected |
|---|---|---|---|
| Quercetin | COX-2 | −9.6 | −7 to −9 |
| Genistein | ERα | −6.9 | −8 to −10 |
| Glucose | COX-2 | −6.2 | −3 to −5 |
Every report is structured to move directly into R&D workflows — no reformatting, no interpretation gap.
Ranked binding affinities across all 7 female-relevant receptors — ERα, ERβ, PR, AR, GR, TRα, TRβ — with kcal/mol scores and Boltz-2 confidence ratings for top hits.
A full compound-level mapping from your ingredient's bioactive panel to the receptor it most plausibly engages — the molecular rationale behind your formula's claims.
Prioritized ingredient recommendations with trade-off analysis — coverage breadth vs. constraint fit — designed to be forwarded to your CMO or R&D team without rework.
We work with product, R&D, and brand teams at premium wellness companies who need more than a literature review.
You're launching a hormone-health SKU and need defensible, mechanism-level rationale for every ingredient — not just trademarked blends and vague citations.
You want to move beyond "adaptogen" positioning and build claims grounded in receptor-level binding data your science team can stand behind.
You're evaluating botanical ingredients at speed and need a fast, structured screen before committing to clinical investment or CMO formulation trials.
Tell us your ingredient focus and we'll send a sample showing exactly the depth and format of what you'd receive.